Veeva Commercial & Medical Summit, North America —Veeva
Systems (NYSE:VEEV) today introduced a new commercial data warehouse
for life sciences. Veeva
Nitro eliminates the burden of custom-built data warehouses with an
industry-specific data model and standard integrations that unify
companies’ most important data sources. Now the life sciences industry
will have a ready-to-use commercial data warehouse in the cloud that is
tailored to its needs with the ease of implementation, configuration,
and ongoing enhancements that come with a packaged software solution.
With Veeva Nitro, the industry will finally have the right commercial
data foundation for artificial intelligence (AI) and analytics to
deliver business insights faster.

“Custom data warehouses are inherently inflexible, so it can take weeks
to get answers to important questions every time a new data source is
added or systems change,” said Dan Utzinger, vice president and CIO at
Intra-Cellular Therapies, and former VP of IT at Eisai. “An
industry-specific commercial data warehouse in the cloud provides a
significant opportunity to accelerate speed to value by delivering
actionable insights for better decision-making, as well as lay the
foundation to fully leverage the power of advanced analytics and AI.”

Because of the lack of a high-quality, packaged commercial data
warehouse solution, companies build and maintain their own, requiring
significant time and resources. These custom-built solutions are not
quickly adaptable as business requirements evolve and data structures
and sources change. This delays insights from reaching the business and
leaves organizations ill-equipped to support AI.

“A packaged commercial data warehouse in the cloud has the potential to
be a game changer for life sciences,” said Eric Newmark, program vice
president for IDC’s cloud, SaaS, and industry cloud practice. “It’s
encouraging to see the next evolution of industry cloud software will
include a data warehouse built for life sciences in an effort to finally
make custom data warehouses the exception, not the rule.”

Veeva Nitro is a global solution that meets organizations’ unique
regional requirements, including specialized data sources and business
processes. Its extensible data model is based on deep industry best
practices, while seamless integration with Veeva
CRM Suite and Veeva
Vault PromoMats automatically syncs all customer activity data and
information about a company’s content and its usage into the data
warehouse. Also, industry data connectors are capable of bringing
together data from the most common sources such as prescription, sales,
formulary, and claims data, including regional data from IQVIA and
Encise.

Veeva Nitro is analytics-ready so companies can get business insights
faster. Customers have the flexibility to use the business intelligence
(BI) and AI tools of their choice, as well as deliver tailored data
visualization to field teams through Veeva CRM MyInsights, to
immediately generate insights and drive informed action.

“Veeva aims to eliminate the burden of custom-built data warehouses to
help customers execute with much greater speed and agility,” said Peter
Gassner, Veeva CEO and founder. “Veeva Nitro will bring the right data
together so customers can uncover insights that were never before
possible and enable intelligent customer engagement.”

Veeva Nitro is built on Amazon
Redshift— powerful petabyte-scale data
warehouse infrastructure in the cloud — to ensure the highest levels of
scalability and fast-query performance even on the largest data sets.

In other news today, Veeva announced new mobile innovations in Veeva
CRM to empower field teams with the right information they need from
any device. Read our press
release to learn how Veeva CRM’s new real-time architecture and Sunrise
user interface improve field execution and productivity.

Veeva Nitro is available today in Japan, and is expected to be available
in North America by the end of 2018. Learn more at veeva.com/eu/Nitro.

What the Industry is Saying:

“The current explosion of data comes as a double-edged sword. It can
offer customer insights in ways that were never before possible, but it
can also overwhelm and frustrate organizations that are not equipped to
harness it,” said David Ehrlich, president and CEO of Aktana. “Veeva
Nitro will modernize data warehousing and establish a flexible cloud
foundation that enables Aktana to better anticipate and serve the
decision support needs of our customers.”

“Increasing data’s availability and reliability enhances analytics’
value in driving more opportunities. Combining Veeva Nitro with Qlik’s
associative engine will enhance life sciences’ ability to execute at a
higher level across the organization and in the field through
analytics,” said Mike Potter, CTO at Qlik. “As a longtime Veeva partner,
we’re excited about the tremendous potential of Veeva Nitro to help life
sciences customers derive more insights and outcomes from their data.”

“Life Sciences companies are challenged to address data sourced from
increasingly diverse, disparate, and rapidly changing sources”, said
Andy De, Senior Director, healthcare and life sciences at Tableau
Software. “Veeva will empower Pharma companies with the agility to
manage the variety and volume of their data with an industry-specific
data warehouse and visual analytics from Tableau that will evolve and
keep pace with their business.”

About Veeva Systems
Veeva Systems Inc. is a leader in
cloud-based software for the global life sciences industry. Committed to
innovation, product excellence, and customer success, Veeva has more
than 600 customers, ranging from the world's largest pharmaceutical
companies to emerging biotechs. Veeva is headquartered in the San
Francisco Bay Area, with offices in Europe, Asia, and Latin America. For
more information, visit www.veeva.com/eu.

Forward-looking Statements
This release contains
forward-looking statements, including the market demand for and
acceptance of Veeva’s products and services, the results from use of
Veeva’s products and services, and general business conditions,
particularly in the life sciences industry. Any forward-looking
statements contained in this press release are based upon Veeva’s
historical performance and its current plans, estimates, and
expectations, and are not a representation that such plans, estimates,
or expectations will be achieved. These forward-looking statements
represent Veeva’s expectations as of the date of this press
announcement. Subsequent events may cause these expectations to change,
and Veeva disclaims any obligation to update the forward-looking
statements in the future. These forward-looking statements are subject
to known and unknown risks and uncertainties that may cause actual
results to differ materially. Additional risks and uncertainties that
could affect Veeva’s financial results are included under the captions,
“Risk Factors” and “Management’s Discussion and Analysis of Financial
Condition and Results of Operations” in the company’s filing on Form
10-K for the period ended January 31, 2018. This is available on the
company’s website at veeva.com
under the Investors section and on the SEC’s website at sec.gov.
Further information on potential risks that could affect actual results
will be included in other filings Veeva makes with the SEC from time to
time.